2022
DOI: 10.1016/j.jsbmb.2022.106153
|View full text |Cite
|
Sign up to set email alerts
|

Spatiotemporal expression pattern of Progesterone Receptor Component (PGRMC) 1 in endometrium from patients with or without endometriosis or adenomyosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 33 publications
2
3
0
Order By: Relevance
“…We measured both mRNA and protein levels of PGRMC1 after inducing decidualization and observed a rise-to-decline pattern. The observed increase and decrease of PGRMC1 protein expression ts into cyclic changes observed in vivo [30]. The overall dynamic changes of the PGRMC1 protein level during a normal menstrual cycle are composed of two peaks: one occurs in the secretory phase, as revealed in this study and the other one occurs in the proliferative phase as previously reported [9,30].…”
Section: Discussionsupporting
confidence: 84%
See 2 more Smart Citations
“…We measured both mRNA and protein levels of PGRMC1 after inducing decidualization and observed a rise-to-decline pattern. The observed increase and decrease of PGRMC1 protein expression ts into cyclic changes observed in vivo [30]. The overall dynamic changes of the PGRMC1 protein level during a normal menstrual cycle are composed of two peaks: one occurs in the secretory phase, as revealed in this study and the other one occurs in the proliferative phase as previously reported [9,30].…”
Section: Discussionsupporting
confidence: 84%
“…In a normal menstrual period, PGRMC1 mRNA level gradually decreased from the proliferative phase to the secretory (including early-, mid-, and late-) phase, manifesting the highest level in the proliferation phase and the lowest level in the late-secretory phase (Fig. 1A-B), consistent with previously reported data [9,30]. This indicates that PGRMC1 may have an important role in regulating cellular proliferation and may not be required for decidualization in the secretory phase as it is consecutively decreased at mRNA level after progesterone stimulation.…”
Section: Pgrmc1 Expression Is Dysregulated In Patients With Impaired ...supporting
confidence: 92%
See 1 more Smart Citation
“…Menstrual cycle and diseases affecting the uterus are characterized by changes in the lipid metabolism of the tissues . In the course of a study of hormonal changes during the menstrual cycle and their relation with endometriosis, it was decided to test the matrix transfer protocol on human uterine tissue sections, a biological sample type that has never been studied in MSI to the best of our knowledge. Preliminary reference sample imaging using 30 keV Bi 5 + primary ions highlighted two different tissues, as shown in Figure a: (1) the myometrium, which is a muscular wall that allows the expulsion of the fetus, and (2) the endometrium, which is a dynamic tissue that grows, matures, and is degraded during the menstrual cycle.…”
Section: Resultsmentioning
confidence: 99%
“…However, the expression of progesterone receptor (PR) is downregulated or absent in the ectopic lesions of AM patients compared with healthy controls, resulting in progesterone resistance. As a result, the proliferative effect of excess estrogen cannot be countered by progesterone ( Mehasseb et al, 2011 ; Thieffry et al, 2022 ). The increase in estrogen not only induces endometrial proliferation and repair through the estradiol receptor β (ERβ), but also promotes the secretion of oxytocin through the estradiol receptor α (ERα), which continuously stimulates the uterus to be in a state of peristalsis and damage, causing the uterus to enter a vicious cycle of chronic damage, proliferation and inflammation.…”
Section: Pathogenesis Of Ammentioning
confidence: 99%